首页|运用网络药理学探索血府逐瘀汤治疗胶质母细胞瘤分子机制

运用网络药理学探索血府逐瘀汤治疗胶质母细胞瘤分子机制

Using network pharmacology to explore the molecular mechanism of Xuefu Zhuyu decoction in treating glioblastoma

扫码查看
目的 胶质母细胞瘤(GBM)是严重危害全球人类健康的最致命疾病之一.血府逐瘀汤(XFZYD)是活血化瘀的方剂.虽然XFZYD已被证明能抑制肿瘤细胞的迁移和侵袭,但其活性成分、潜在靶点和潜在机制仍不清楚.研究目的是通过网络药理学来探索 XFZYD 治疗 GBM 的分子机制.方法 下载GEO数据库中GBM基因表达矩阵,运用TCMSP数据库筛选XFZYD的活性成分及其作用靶点;进一步通过吸收、分布、代谢和排泄(ADME)特性进行活性化合物筛选;对XFZYD活性成分作用靶点与GBM差异表达基因取交集(共同靶点),即得XFZYD治疗GBM 的潜在作用靶点;采用Cytoscape 软件构建XFZYD的"活性成分-作用靶点"网络;对共同靶点进行蛋白互作(PPI)网络分析、功能富集分析.结果 我们通过吸收、分布、代谢和排泄(ADME)筛选确定了 117 种活性组分,差异表达分析鉴定出 2 265 个差异基因,表达上调的基因 1 192 个,表达下调基因是 1 073 个.由成分-靶标网络和GBM相关基因整合的成分-靶标-致病基因(C-T-P)网络显示XFZYD可通过 72 个相关差异基因来治疗GBM,进一步通过Cytoscape中CytoNCA插件和MCODE插件分析组分-靶标-致病基因网络(C-T-P网络),结果提示EGFR,BCL2 和FOS为核心基因.功能分析提示XFZYD主要通过PI3K-Akt信号通路来治疗GBM.结论XFZYD具有多成分、多靶点、多通路的特点,主要与PI3K-Akt信号通路相关.
Objective Glioblastoma(GBM)is one of the most deadly diseases that seriously endanger human health all over the world.Xuefu Zhuyu Decoction(XFZYD)is a prescription for promoting blood circulation and removing blood stasis.Although XFZYD has been proved to inhibit the migration and invasion of tumor cells,its active components,potential targets and potential mechanisms are still unclear.The purpose of this study is to explore the molecular mechanism of XFZYD in treating GBM through network pharmacology.Methods GBM gene expression matrix was downloaded from GEO database,and the active components and targets of XFZYD were screened by TCMSP database.Further screening the active compounds by absorption,distribution,metabolism and excretion(ADME)characteristics;Take the intersection(common target)between the target of XFZYD active ingre-dient and the differentially expressed gene of GBM to obtain the potential target of XFZYD in treating GBM;The"active ingredi-ent-target"network of XFZYD was constructed by Cytoscape software.Protein-protein interaction(PPI)network analysis and func-tional enrichment analysis were performed on the common targets.Results We identified 117 active components by absorption,distribution,metabolism and excretion(ADME)screening,and identified 2265 differential genes by differential expression analysis,including 1 192 genes with up-regulation and 1 073 genes with down-regulation.The component-target-pathogenic gene(C-T-P)network integrated by component-target network and GBM-related genes shows that XFZYD can treat GBM through 72 related dif-ferential genes,and then the component-target-pathogenic gene network(C-T-P network)is analyzed by CytoNCA plug-ins and MCODE plug-ins in Cytoscape.The results suggest that EGFR,BCL2-2 and FOS are the core genes.Functional analysis suggests that XFZYD mainly treats GBM through PI3K-Akt signaling pathway.Conclusion XFZYD has the characteristics of multi-com-ponent,multi-target and multi-channel,which is mainly related to PI3K-Akt signal pathway.

Xuefu ZhuyuTangnetwork pharmacologyglioblastomamolecular mechanismdifferentially expressed genes

杨小刚、杨春丽、黄翠兰、方武、林志颖

展开 >

江西省人民医院南昌医学院第一附属医院

南昌大学江西医学院,南昌 330006

血府逐瘀汤 网络药理学 胶质母细胞瘤 分子机制 差异表达基因

2024

江西医药
江西省医学会

江西医药

影响因子:0.793
ISSN:1006-2238
年,卷(期):2024.59(10)